Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Trellus Health signs deal with large US health plan

(Sharecast News) - Digital health company Trellus Health announced a significant agreement with a major US health plan on Wednesday, targeting inflammatory bowel disease (IBD) management. The AIM-traded firm said that under the terms of the agreement, spanning up to 21 months, eligible members of the health plan residing in two US states would gain access to Trellus Health's 'Elevate' IBD programme.

It said the programme aimed to enhance outcomes and reduce costs associated with IBD care through digital health interventions.

Trellus Health said its Elevate IBD programme leverages scientifically-validated methodologies to address the complex interplay between physical and mental health in chronic conditions like IBD.

By prioritising holistic care, the programme looked to improve patient well-being while containing healthcare expenditure.

At 1256 GMT, shares in Trellus Health were down 6.67% at 3.5p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Frontier IP's Alusid launches another range with Topps Tiles
(Sharecast News) - Frontier IP announced on Friday that its portfolio company Alusid has launched its first range of floor tiles through Parkside Architectural Tiles, the commercial division of Topps Tiles.
Enteq appoints new head of finance
(Sharecast News) - Energy service engineering and technology company Enteq announced the appointment of Amir Absoud as its head of finance on Friday, to immediately succeed the current chief financial officer, Mark Ritchie.
EnSilica to raise £0.3m through retail offer
(Sharecast News) - EnSilica announced a retail offer through the Winterflood Retail Access Platform (WRAP) on Friday, to raise up to £0.3m.
Recurring revenue, adjusted earnings rise for Pulsar Group
(Sharecast News) - Audience intelligence software specialist Pulsar Group said in its final results on Friday that its annualised recurring revenue (ARR) increased £2.7m, a significant improvement from the flat performance in the prior financial year.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.